National Cancer Institute
Found 21 results for your search:
Total relevant funding to Gene Therapy Clinical Trials for this search:
$6,605,745
Fiscal Year FY 2017
Research Topic [Gene Therapy Clinical Trials]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 21 of 21 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
Adoptive Cell Transfer Immunotherapy of Cancer ZIA BC 010984 $1,629,581 $651,832 Rosenberg, Steven CCR (NCI)
2
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $13,582 $2,716 Kochenderfer, James CCR (NCI)
3
Building on the success of the adoptive immunotherapy of cancer ZIA BC 010763 $1,562,883 $390,721 Restifo, Nicholas CCR (NCI)
4
Cell Production Core Facility ZIC BC 011569 $933,290 $466,645 Somerville, Robert CCR (NCI)
5
Clinical production of viral vectors for cancer gene therapy ZIC BC 010989 $556,461 $556,461 Feldman, Steven CCR (NCI)
6
Development of fully-human anti-CD30 chimeric antigen receptors ZIA BC 011660 $67,909 $67,909 Kochenderfer, James CCR (NCI)
7
DF/HCC Kidney Cancer SPORE 5P50CA101942-13 $2,300,000 $276,000 MCDERMOTT, DAVID BETH ISRAEL DEACONESS MEDICAL CENTER
8
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome 5R01CA143167-07 $407,577 $407,577 HILL, DANA CHILDREN'S RESEARCH INSTITUTE
9
Gene therapy of cancer ZIA BC 010985 $1,629,581 $651,832 Rosenberg, Steven CCR (NCI)
10
Immune cell control of ovarian cancer ZIA BC 011775 $309,150 $61,830 Annunziata, Christina CCR (NCI)
11
Immuno-Targeted Therapy for Melanoma 5R35CA197633-03 $899,241 $269,772 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA LOS ANGELES
12
SPORE in Cervical Cancer 5P50CA098252-14 $2,300,000 $299,000 WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY
13
SPORE in Prostate Cancer 5P50CA058236-22 $1,993,426 $398,685 NELSON, WILLIAM JOHNS HOPKINS UNIVERSITY
14
SPORE in Skin Cancer 5P50CA174523-04 $2,300,000 $92,000 HERLYN, MEENHARD WISTAR INSTITUTE
15
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer 5P50CA070907-19 $2,299,998 $460,000 MINNA, JOHN UT SOUTHWESTERN MEDICAL CENTER
16
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient 5U01CA183012-04 $312,304 $156,152 ZAIA, JOHN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
17
Surgery Branch Cell Prep Core ZIC BC 010905 $933,290 $466,645 Wunderlich, John CCR (NCI)
18
T-cell receptor gene therapy for human papillomavirus-positive cancers ZIA BC 011479 $671,060 $503,295 Hinrichs, Christian CCR (NCI)
19
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man 5R01CA164333-05 $352,335 $176,168 KOYA, RICHARD ROSWELL PARK CANCER INSTITUTE CORP
20
The Antigen Targeting Core ZIC BC 011030 $225,010 $112,505 Parkhurst, Maria CCR (NCI)
21
Translational Research in Breast Cancer (SPORE) 5P50CA186784-04 $2,300,000 $138,000 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
Total relevant funding to Gene Therapy Clinical Trials for this search: $6,605,745
Showing 1 - 21 of 21 results
Go to top